SGLT2 Inhibitors in Type 2 DM: A Cardiorenal "Game-Changer"
medcases00
Published on Aug 22, 2021
A Division of Hospital Medicine Grand Rounds presented by Steven Coca, DO, MS, Associate Chair for Clinical and Translational Research, Associate Professor of Medicine (Nephrology)
Category
Add to
Please Sign In or Create Account to use this feature!
Flag Video
Please Sign In or Create Account to use this feature!
Rate video
Please Sign In or Create Account to use this feature!
Rate video
Please Sign In or Create Account to use this feature!
Up next
Autoplay
Autoplay
Recommended
-
Watch Later
01:02:49"Cardio-renal Risk Reduction Across the Spectrum of Type 2 DM" presented by Anip Bansal
15 views 832 days ago -
Watch Later
34:00Iris De Castro, MD - SGLT2 inhibitor in Kidney Transplantation: Is it ready for prime time?
16 views 1088 days ago -
Watch Later
45:18Onconephrology Updates: Immune Checkpoint Inhibitors and Kidney Injury
16 views 834 days ago -
Watch Later
!["Not Again! Recurrent Disease After Kidney Transplant", by Priya Verghese, MD, MPH]()
51:21"Not Again! Recurrent Disease After Kidney Transplant", by Priya Verghese, MD, MPH
12 views 792 days ago -
Watch Later
!["Updates in Adult Minimal Change Disease" presented by Ruth Campbell]()
51:21"Updates in Adult Minimal Change Disease" presented by Ruth Campbell
16 views 814 days ago -
Watch Later
!["Atypical Uses of Peritoneal Dialysis" presented by Ruth Campbell]()
37:35"Atypical Uses of Peritoneal Dialysis" presented by Ruth Campbell
13 views 814 days ago
